Published: Jan 19, 2026
Written by Klarity Editorial Team
Published: Jan 19, 2026

In recent years, telehealth has revolutionized how patients access healthcare, particularly for conditions like Binge Eating Disorder (BED). As digital healthcare evolves, many patients wonder about the legality and safety of receiving BED medications through virtual platforms. This comprehensive guide examines the current landscape of telehealth prescribing for non-controlled medications commonly used to treat BED.
Good news for those seeking BED treatment: non-controlled medications for BED can legally be prescribed via telehealth in all 50 states. While there’s been much discussion about telehealth restrictions, these primarily affect controlled substances (like stimulants and opioids).
The most common off-label medications prescribed for BED—Topamax (topiramate) and Wellbutrin (bupropion)—are not controlled substances. This means they’re exempt from the strict federal Ryan Haight Act restrictions that apply to medications like Vyvanse (which is FDA-approved for BED but is a controlled stimulant).
As of 2026, telehealth prescribing for non-controlled medications remains widely accessible, with federal policy continuing to support virtual care options. The DEA’s latest extension of telehealth flexibilities through December 2026 reinforces this trend, though it primarily impacts controlled substances rather than the non-controlled medications typically used for BED.
While telehealth prescribing of non-controlled medications is permitted nationwide, some state-specific nuances exist:
Most states (including California, Delaware, New York, and Michigan) have no in-person requirement for prescribing non-controlled medications via telehealth.
A few states like Georgia and Alabama require periodic in-person follow-ups (typically within 12 months) for ongoing telehealth treatment, though the initial prescription can still be made virtually.
States continue to modernize their telehealth laws. For example, New Hampshire recently updated its regulations to explicitly allow telehealth prescribing with an annual in-person follow-up.
The authority to prescribe varies by provider type and state regulations:
Physicians (MDs and DOs) can prescribe these medications in all states.
Nurse Practitioners (NPs) can prescribe in all states, but their level of autonomy differs:
In approximately 34 states plus DC, NPs have full practice authority
Recent additions to this list include Wisconsin and Michigan (2025)
In states like Texas and Florida, NPs require collaborative agreements with physicians
Physician Assistants (PAs) can also prescribe these medications but typically work under physician supervision or collaboration.
At Klarity Health, we connect patients with licensed providers who understand the specific telehealth prescribing rules in your state, ensuring you receive appropriate care within the legal framework.
When seeking BED medication through telehealth, a legitimate provider will:
Not everyone is an ideal candidate for telehealth BED medication. Providers screen for conditions that might require in-person care or make certain medications unsafe:
Expect regular telehealth follow-up appointments, especially during the initial phase of treatment. While these medications can often be prescribed with refills (unlike controlled substances), monitoring your response and adjusting as needed is essential for safe, effective treatment.
Reputable telehealth providers implement strict protocols to maintain high standards of care:
At Klarity Health, we prioritize patient safety through comprehensive evaluations, evidence-based prescribing practices, and consistent follow-up care. Our providers are licensed in your state and follow all applicable regulations to ensure you receive appropriate, legal care for your BED symptoms.
Be cautious of telehealth services that:
Telehealth has made BED treatment more accessible than ever while maintaining appropriate safeguards. For non-controlled medications like Topamax and Wellbutrin, the regulatory landscape favors patient access—you can legally receive these prescriptions via telehealth in every state.
The key is finding a reputable telehealth provider who conducts thorough evaluations, follows state-specific regulations, and provides consistent follow-up care. With the right provider, telehealth offers a convenient, effective path to BED treatment that maintains the same standards as in-person care.
If you’re struggling with binge eating symptoms, consider reaching out to Klarity Health to connect with a qualified provider who can evaluate your symptoms and discuss treatment options, including whether medication might be appropriate for your situation.
Q: Do I need an in-person visit before getting BED medication via telehealth?
A: For non-controlled medications like Topamax and Wellbutrin, most states don’t require an in-person visit. A few states like Georgia and Alabama require periodic in-person follow-ups (within 12 months) for ongoing care.
Q: Are these medications FDA-approved for BED?
A: No. While Vyvanse is FDA-approved for BED, Topamax and Wellbutrin are prescribed off-label based on clinical evidence supporting their effectiveness. Off-label prescribing is legal, common, and often supported by treatment guidelines.
Q: Will my insurance cover telehealth prescriptions for BED?
A: Most major insurers now cover telehealth visits, though coverage for specific medications varies by plan. Be sure to check your specific coverage. Many telehealth providers also offer transparent cash pricing as an alternative.
**Q: How long can I receive B
Find the right provider for your needs — select your state to find expert care near you.